Pelthos Therapeutics (PTHS) Cash & Equivalents (2022 - 2026)
Pelthos Therapeutics' Cash & Equivalents came in at $24.19 million for Q2 2026, compared with $59,000 a year earlier and down 24.3% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Pelthos Therapeutics' Cash & Equivalents was $17.97 million.
- Cash & Equivalents carries a three-year compound annual growth rate of 588.5% (FY2022 to FY2025).
- Going back by year, Cash & Equivalents was $513,000 in FY2024 (+434.4%), $96,000 in FY2023 (+74.3%) and $55,074 in FY2022.
- The five-year range for quarterly Cash & Equivalents is $22,786 (Q3 2023) to $31.98 million (Q1 2026).
- Business Quant data shows PTHS's Cash & Equivalents at $31.98 million (Q1 2026), $17.97 million (Q4 2025) and $14.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Pelthos Therapeutics | 33.36 Mn | -55.04 Mn | 11.99 Mn | 24.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.19 Mn |
| Mar 31, 2026 | 31.98 Mn |
| Dec 31, 2025 | 17.97 Mn |
| Sep 30, 2025 | 14.25 Mn |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Dec 31, 2024 | 513,000.00 |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 22,786.00 |
| Jun 30, 2023 | 81,893.00 |
| Mar 31, 2023 | 48,608.00 |
| Dec 31, 2022 | 55,074.00 |
API Access
Pelthos Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();